Fly News Breaks for March 4, 2020
Mar 4, 2020 | 16:45 EDT
Citi analyst Joanne Wuensch initiated coverage of Zimmer Biomet with a Buy rating and $168 price target. The analyst notes the company is a "different organization" than it was two years ago with a combination of new management, a refreshed portfolio, a cultural makeover, and a restored effort on quality/manufacturing, adding that 2020 should be a year of revenue acceleration, with potential tuck-in M&A and strong momentum of its robotics franchise.
News For ZBH From the Last 2 Days
There are no results for your query ZBH